Assurance Biosense is focused on creating a simple, single-point-of-contact sensor that can reliably monitor critical parameters for all patients and provide clinicians an early warning of impending events.
The Assurance®Alar Sensor is the next generation of pulse oximetry. The sensor is placed on the fleshy part of the side of the nose. This region has the same central blood supply as the brain. The alar site provides a strong, reliable signal, even when it is difficult to get a signal at the extremities.
Assurance Biosense, Inc. is a wholly-owned subsidiary of Xhale, Inc.